{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T04:44:01Z","timestamp":1773549841253,"version":"3.50.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T00:00:00Z","timestamp":1382400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077461","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T22:01:17Z","timestamp":1382479277000},"page":"e77461","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs"],"prefix":"10.1371","volume":"8","author":[{"given":"Nadia","family":"Oreshkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucien","family":"van Keulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jet","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J. M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"GH Gerdes","year":"2004","journal-title":"Rev Sci Tech"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3201\/eid1504.081045","article-title":"Rift Valley fever, Mayotte, 2007\u20132008","volume":"15","author":"D Sissoko","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3201\/eid1707.102031","article-title":"Rift valley fever in ruminants, Republic of Comoros, 2009","volume":"17","author":"M Roger","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref4","first-page":"905","article-title":"Outbreak of Rift Valley fever - Saudi Arabia, August-October, 2000","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","first-page":"1065","article-title":"Outbreak of Rift Valley Fever Virus - Yemen, August-October 2000","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","first-page":"205","article-title":"The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs","volume":"44","author":"JA Coetzer","year":"1977","journal-title":"Onderstepoort J Vet Res"},{"key":"ref7","first-page":"11","article-title":"The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses","volume":"49","author":"JA Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"key":"ref8","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"BC Easterday","year":"1965","journal-title":"Adv Vet Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"TA Madani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0035-9203(79)90006-3","article-title":"Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness","volume":"73","author":"LW Laughlin","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"M Pepin","year":"2010","journal-title":"Vet Res"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Elliott RM (1996) The Bunyaviridae. New York &amp; London: Plenum Press.","DOI":"10.1007\/978-1-4899-1364-7"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"A Billecocq","year":"2004","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"M Bouloy","year":"2001","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation","volume":"5","author":"T Ikegami","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","article-title":"Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR","volume":"1171","author":"T Ikegami","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"M Habjan","year":"2009","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/JVI.62.3.826-833.1988","article-title":"Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression","volume":"62","author":"LT Kakach","year":"1988","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"SY Won","year":"2007","journal-title":"Journal of Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/vbz.2008.0009","article-title":"Potential vectors of Rift Valley fever virus in the Mediterranean region","volume":"8","author":"S Moutailler","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.2807\/ese.15.10.19506-en","article-title":"Rift Valley fever\u2014a threat for Europe?","volume":"15","author":"V Chevalier","year":"2010","journal-title":"Euro Surveill"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S0950268809990367","article-title":"Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion","volume":"138","author":"P Gale","year":"2010","journal-title":"Epidemiol Infect"},{"key":"ref23","first-page":"529","article-title":"Global change: impact, management, risk approach and health measures\u2014the case of Europe","volume":"27","author":"B Dufour","year":"2008","journal-title":"Rev Sci Tech"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2460\/javma.232.4.514","article-title":"Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States","volume":"232","author":"TR Kasari","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268812002245","article-title":"\u2018Schmallenberg virus\u2019\u2014a novel orthobunyavirus emerging in Europe","volume":"141","author":"M Beer","year":"2013","journal-title":"Epidemiol Infect"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"B Botros","year":"2006","journal-title":"J Med Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"SA Kamal","year":"2009","journal-title":"Virol J"},{"key":"ref28","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"BJ Barnard","year":"1977","journal-title":"J S Afr Vet Assoc"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"B Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"B von Teichman","year":"2011","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66 (Pt 10)","author":"H Caplen","year":"1985","journal-title":"J Gen Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"JF Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"JC Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further Evaluation of a Mutagen-Attenuated Rift-Valley Fever Vaccine in Sheep","volume":"9","author":"JC Morrill","year":"1991","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref37","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"P Hunter","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"JC Morrill","year":"2013","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Morrill JC, Laughlin RC, Lokugamage N, Wu J, Pugh R, <etal>et al<\/etal>.. (2013) Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine.","DOI":"10.1016\/j.vaccine.2013.08.003"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"BH Bird","year":"2011","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2009.08.002","article-title":"Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines","volume":"84","author":"M Bouloy","year":"2009","journal-title":"Antiviral Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift Valley Fever: Recent Insights into Pathogenesis and Prevention","volume":"85","author":"H Boshra","year":"2011","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"T Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcimb.2012.00131","article-title":"Novel approaches to develop Rift Valley fever vaccines","volume":"2","author":"SV Indran","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"J Kortekaas","year":"2011","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JVI.07104-11","article-title":"Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","volume":"86","author":"KA Dodd","year":"2012","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"J Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Antonis AFG, Kortekaas JA, Kant J, Vloet RPM, Vogel-Brink A, <etal>et al<\/etal>.. (2013) Vertical transmission of Rift Valley fever virus without detectable maternal viremia. Vector-Borne and Zoonotic Diseases.","DOI":"10.1089\/vbz.2012.1160"},{"key":"ref49","first-page":"155","article-title":"Rift Valley fever vaccine\u2014antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"BJ Barnard","year":"1979","journal-title":"J S Afr Vet Assoc"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"H Niwa","year":"1991","journal-title":"Gene"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","article-title":"Use of Bacterial Expression Cloning to Define the Amino-Acid-Sequences of Antigenic Determinants on the G2-Glycoprotein of Rift-Valley Fever Virus","volume":"58","author":"K Keegan","year":"1986","journal-title":"J Virol"},{"key":"ref52","first-page":"191","article-title":"Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells","volume":"302","author":"GA Cole","year":"2005","journal-title":"Methods Mol Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pntd.0000725","article-title":"Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus","volume":"4","author":"N Bhardwaj","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.gt.3301335","article-title":"Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB\/c mice: identification of an H2-Kd-restricted CTL epitope","volume":"7","author":"A Gambotto","year":"2000","journal-title":"Gene Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.antiviral.2008.12.009","article-title":"Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice","volume":"81","author":"P Tao","year":"2009","journal-title":"Antiviral Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"SM de Boer","year":"2010","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"G K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie und Pharmakologie"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.2044-8295.1908.tb00176.x","article-title":"The method of \u2018right and wrong cases\u2019 (\u2018constant stimuli\u2019) without gauss&apos;s formulae","volume":"2","author":"C Spearman","year":"1908","journal-title":"British Journal of Psychology, 1904\u20131920"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.vaccine.2010.01.001","article-title":"Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus","volume":"28","author":"J Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1128\/JVI.76.23.12200-12210.2002","article-title":"Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein","volume":"76","author":"SR Gerrard","year":"2002","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"R Gorchakov","year":"2007","journal-title":"Virology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2007.12.002","article-title":"Endocytosis mechanisms and the cell biology of antigen presentation","volume":"20","author":"S Burgdorf","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0161-5890(01)00069-4","article-title":"Presentation of antigens by MHC class II molecules: getting the most out of them","volume":"38","author":"JA Villadangos","year":"2001","journal-title":"Mol Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"PY Lozach","year":"2011","journal-title":"Cell Host Microbe"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:55:55Z","timestamp":1746035755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077461"}},"subtitle":[],"editor":[{"given":"Kylene","family":"Kehn-Hall","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,22]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077461","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,22]]}}}